Extracellular serine protease

Details Extracellular serine protease Extracellular serine protease

2007-01-02

2007-01-02

Chan, Christina (Department: 1644)

Drug, bio-affecting and body treating compositions

Enzyme or coenzyme containing

Hydrolases

C424S184100, C435S007240, C435S372000, C530S328000, C530S350000

Reexamination Certificate

active

09796294

ABSTRACT:
The present invention provides a DNA encoding a novel extracellular serine protease termed Tumor Antigen Derived Gene-14 (TADG-14) which is overexpressed in ovarian, breast and colon carcinoma samples. Also provided are vector and host cells capable of expressing the DNA of the present invention, as well as the uses of the DNA and protein of the present invention.

REFERENCES:
patent: 6080409 (2000-06-01), Laus et al.
patent: 6100059 (2000-08-01), Southan et al.
patent: 6203979 (2001-03-01), Bandman et al.
Stryer et al, in Biochemistry, Third edition, W H Freeman Company, New York, pp. 31-33, 1998.
Ngo et al, 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Engleman et al, Cytotechnology 25(1-3):1-8, 1997.

Affiliated with

Also associated with

Rating

Extracellular serine protease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Extracellular serine protease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extracellular serine protease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3726293